Opko Health Inc (NASDAQ:OPK) shares, rose in value, with the stock price up by 0.74% to the previous day’s close as strong demand from buyers drove the stock to $1.36.
Actively observing the price movement in the last trading, the stock closed the session at $1.35. The value of beta (5-year monthly) was 1.84. Referring to stock’s 52-week performance, its high was $2.24, and the low was $0.85. On the whole, OPK has fluctuated by 45.47% over the past month.
With the market capitalization of Opko Health Inc currently standing at about $947.91 million, investors are eagerly awaiting this quarter’s results, scheduled for May 01, 2024 – May 06, 2024. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be -$0.09, which is expected to increase to -$0.07 for fiscal year -$0.37 and then to about -$0.26 by fiscal year 2025. Data indicates that the EPS growth is expected to be -48.00% in 2025, while the next year’s EPS growth is forecast to be 29.70%.
Analysts have estimated the company’s revenue for the quarter at $182.99 million, with a low estimate of $180 million and a high estimate of $184.8 million. According to the average forecast, sales growth in current quarter could jump down -23.00%, compared to the corresponding quarter of last year. Wall Street analysts also predicted that in 2025, the company’s y-o-y revenues would reach $760.31 million, representing a decrease of -12.00% from the revenues reported in the last year’s results.
Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that OPK’s technical picture suggests that short-term indicators denote the stock is a Hold on average. However, medium term indicators have put the stock in the category of 50% Sell while long term indicators on average have been pointing out that it is a Hold.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of OPK currently trading nearly 34.40% and 35.19% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 81.29, while the 7-day volatility ratio is showing 9.46% which for the 30-day chart, stands at 6.61%. Furthermore, Opko Health Inc (OPK)’s beta value is 1.82, and its average true range (ATR) is 0.08.
A comparison of Opko Health Inc (OPK) with its peers suggests the former has fared considerably weaker in the market. OPK showed an intraday change of 0.74% in last session, and over the past year, it shrunk by -11.69%%.
Data on historical trading for Opko Health Inc (NASDAQ:OPK) indicates that the trading volumes over the past 10 days have averaged 17.58 million and over the past 3 months, they’ve averaged 15.55 million. According to company’s latest data on outstanding shares, there are 773.28 million shares outstanding.
Nearly 52.98% of Opko Health Inc’s shares belong to company insiders and institutional investors own 27.26% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 102.16 million shares as on Mar 15, 2024, resulting in a short ratio of 11.6. According to the data, the short interest in Opko Health Inc (OPK) stood at 14.66% of shares outstanding as of Mar 15, 2024; the number of short shares registered in Feb 15, 2024 reached 97.94 million. The stock has fallen by -9.93% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the OPK stock heading into the next quarter.
